Iksuda Therapeutics

Herschel Annex
Kings Gate
Newcastle upon Tyne
NE1 7RU
United Kingdom

Activities

R and D | Biotechnology

Related Content

LegoChem and Iksuda expand ADC license agreement

ADC developer Iksuda Therapeutics closes $47m financing round

Iksuda releases first data on ADC efficacy on tumour regression

Iksuda and Femtogenix ink solid tumour agreement

Glythera announces corporate name change and rebranding

Glythera and Cancer Research UK announce licence agreement

Glythera launch project to bring new oncology focused therapies

Avacta to collaborate with Glythera to develop antibody-drug conjugates

BioOutsource partners Glythera to expand ADC characterisation capabilities

UK biotechnology firm Glythera receives funding boost of £700,000

Jobs and People

Glythera appoints Professor Kerry Chester to SAB

Glythera appoints Chief Scientific Officer and strengthens SAB

Glythera appoints Dr Mike Owen as Non-Executive Director

Glythera appoints Scientific Advisory Board

Glythera makes two senior appointments

Similar Companies